Record overview
Status and phase
Status: COMPLETED
Phase: PHASE1, PHASE2
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Condition: Solid Tumor
NCT05991349
A Study of IBI129 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Completed No Results Found Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.